Medennium Showcases Innovative Ophthalmic Solutions and Expands Global Collaboration Opportunities at the 2024 ESCRS Exhibition

Medennium made a noteworthy appearance at the 2024 ESCRS (European Society of Cataract and Refractive Surgeons) exhibition, showcasing its innovative products and solutions to an audience of over 10,000 leading doctors, experts, and suppliers from around the globe. As an innovator in the field of cataract and refractive surgery, Medennium’s booth attracted many attendees, drawing hundreds of visitors eager to learn more about the company’s leading products and technologies.
Highlights included intraocular lenses (IOL), myopia refractive lenses (MPL), and hands-on demonstrations in both dry and wet laboratories. Among the exhibitors, only 11 exhibitors provided dry laboratory demonstrations, with Medennium being one of them. This offering provided valuable practical opportunities for attending doctors and surgeons to experience the latest ophthalmic surgical techniques and products firsthand. As one of the few companies showcasing both dry and wet laboratory, Medennium’s booth attracted many attendees, further emphasizing the company’s significant position in ophthalmic surgical technology innovation. This interactive display not only strengthened Medennium’s connections with global ophthalmic experts but also allowed visitors to experience the company’s technological advantages firsthand, showcasing Medennium’s leadership on the international stage.
During the exhibition, the intraocular lens (IOL) with its variable tint drew significant attention from experts due to its exceptional performance and responsiveness to patient needs. This innovative technology offers a more flexible visual solution, earning high praise from attendees for its remarkable performance and reliable stability. Additionally, the company showcased its star product—Medennium Phakic Lens (MPL)—with its innovative design further illustrating Medennium’s leading position in ophthalmic surgical instruments. In light of the challenges posed by many suppliers unable to ensure timely deliveries within an increasingly complex global supply chain, Medennium highlighted its stable supply chain capabilities, guaranteeing a consistent flow of high-quality products to the international market. The company seized this global platform to engage in meaningful discussions with leading industry doctors, researchers, and suppliers, and laid a solid foundation for future collaboration and the exchange of technology.
During the exhibition, Medennium hosted an exclusive medical focus group, convening 27 renowned ophthalmologists and suppliers from around the world to explore future collaboration opportunities and share insights on the latest industry trends and technological advancements. This event provided a unique forum for industry leaders to engage in in-depth discussions covering pioneering technologies, future development trajectories, and potential avenues for collaboration in cataract and refractive surgery.
The event was honored to welcome Dr. Hoffer, founder of the American Society of Cataract and Refractive Surgery (ASCRS), who delivered the opening address. Other distinguished guests included Dr. Piovella, President of the Italian Ophthalmological Society and an internationally recognized expert in cataract and refractive surgery, and Dr. Khairidzan, Head of the Department of Ophthalmology at the Faculty of Medicine in Malaysia. Additionally, renowned South African ophthalmologist Dr. Johann Kruger and respected industry figure Dr. Dementiev participated in this event. The discussions fostered professional interaction and collaboration among the guests, establishing a solid foundation for the company’s future business expansion.
At this exhibition, Medennium, through its robust innovative capabilities and technological expertise, garnered widespread recognition from experts worldwide. Throughout the event, Medennium communicated its unwavering commitment to technological innovation and global market expansion through interactive displays, highlighting its stable supply capabilities amid global supply chain challenges. As a vital participant in the global ophthalmic market, the company remains dedicated to developing new products and technological innovations, enhancing visual quality at every stage of human life, and producing high-quality, innovative ophthalmic instruments to provide optimal products and services for ophthalmologists and patients, thereby driving the development of the global ophthalmic medical device industry. Looking ahead, Medennium will continue to lead ophthalmic innovation and expand its global market presence, contributing to the improvement of global eye health.

Scroll to Top